Bank Of Nova Scotia Abcam PLC Transaction History

Bank Of Nova Scotia

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$12.62 - $24.47 $109,743 - $212,791	-8,696 Reduced 6.6%	123,030 $3.01 Million
Q1 2023 May 11, 2023	SELL	$12.98 - $17.1 $384,078 - $505,989	-29,590 Reduced 18.34%	131,726 $1.77 Million
Q4 2022 Feb 09, 2023	BUY	$13.92 - $17.0 $11,066 - $13,515	795 Added 0.5%	161,316 $2.51 Million
Q3 2022 Nov 10, 2022	SELL	$13.36 - $16.75 $166,799 - $209,123	-12,485 Reduced 7.22%	160,521 $2.41 Million
Q2 2022 Aug 08, 2022	BUY	$12.69 - $19.25 $121,011 - $183,568	9,536 Added 5.83%	173,006 $2.51 Million
Q2 2022 Aug 05, 2022	BUY	$12.69 - $19.25 $264,066 - $400,573	20,809 Added 14.59%	163,470 $2.37 Million
Q1 2022 May 09, 2022	BUY	$15.5 - $23.89 $77,050 - $118,757	4,971 Added 3.61%	142,661 $2.61 Million
Q4 2021 Feb 11, 2022	BUY	$20.04 - $23.84 $1.5 Million - $1.79 Million	75,000 Added 119.64%	137,690 $3.24 Million
Q3 2021 Nov 12, 2021	BUY	$17.38 - $21.54 $1.09 Million - $1.35 Million	62,690 New	62,690 $1.27 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.